CTP's King stated that the agency was "making significant progress" in reviewing the applications.Read More
Tags :FDA
The London-listed company said the additional restrictions for the products would incur substantial costs. Read More
The court ruled FDA acted within Congress' authorization, and decisions were supported by evidence. Read More
Altria reduced the value of its investment in Juul Labs nearly 70 percent of its original $12.8 billion.Read More
Katherine Ellen Foley, a journalist who covers the FDA for Politico, first announced the news.Read More
The laboratory provides all non-clinical evidence required to bring a new nicotine product to market.Read More
The limited product debut in the UK has received overwhelming recognition from users and commercial partners.Read More
The announcement comes as FDA Commissioner Robert Califf attempts to push past several controversies.Read More
The Fifth Circuit denied the companies' requests Monday for review of the agency’s orders.Read More
Misinformation is misleading information. Disinformation is deliberately deceptive. Read More